Global Payer Evidence Generation Lead
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Søborg
Do you want to make a difference for patients with Rare Diseases and influence healthcare decision-makers to support the positive recommendation and funding of innovative medicines? Are you motivated by optimizing market access and generating payer-relevant real-world evidence generation for new innovative and digital solutions in Novo Nordisk Rare Disease? If yes, then join our team as the Global Payer Evidence Lead! The position As the Payer Evidence Generation Lead, in partnership with Health Economics and Outcomes Research specialists and other relevant subject matter experts, you will be responsible for establishing payer evidence activities and long-term evidence strategies across the Rare Disease portfolio. You will also drive the execution of the plans that ensure the Payer perspectives are included in scientifically sound evidence-generation activities. As the Global Payer Evidence Generation Lead, you will be accountable for building and maintaining a comprehensive network of stakeholders with significant influence on Payer evidence needs. Your role will also involve promoting learning and understanding of Payer evidence expectations for optimal and sustainable access in Rare Disease. Key responsibilities:
• Develop a sound understanding of relevant evidence needed for market access and their HEOR plans including health care resources utilization data, patient reported outcomes, quality of life, and real-world evidence
• Determine and deliver on Payer evidence generation strategies for pipeline products,
• Support payer-relevant clinical studies, including pragmatic studies, real-world evidence programs, patient-costed pathways, epidemiology, treatment patterns, patient preferences, cost, and burden of illness studies
• Key contributor to market access strategy building on best practice / payer-relevant models and evidence generation planning.
• Execute payer relevant evidence programs with high quality collection and statistical analyses expected by payers (PICO, MCID etc.)
• Work cross-functionally with subject matters experts in the identification, collection, synthesis and analysis of real-world datasets, and designing and executing real world pilot studies in partnership with affiliates and their payers and the impactful publication of the results.
Qualifications To be successful in this role, we imagine you should have: • Master’s degree in health economics or outcomes research, epidemiology, or statistics/biostatistics
• At least six years of experience in health economics and health outcomes research, ideally within the pharmaceutical industry or consultancy
• Extensive experience working within market access, digital health, and/or real-world evidence-generation
• Fluency in written and spoken English
On a personal level, it is expected that you have strong project and stakeholder management skills, as well as effective interpersonal communication skills. Be a team player. Additionally, you have a strategic and operational mindset, with a problem-solving approach that can identify solutions and influence decisions.
About the department
Rare Disease Access is a department within Rare Disease, driving change for patients in rare blood and rare endocrine disorders. Market Access is increasingly important for ensuring patients have access to best-in-class products and innovative solutions, as well as the commercial success of pharmaceutical products.
The Rare Disease Access Department is a highly diverse team, responsible for optimizing market access for the continued success of the Rare Disease franchise portfolios. In close collaboration with key internal stakeholders, we establish strategies and key support tactics around pricing, reimbursement, health economics & and outcomes research, and value communication, and subsequently support the implementation nationally, regionally, and locally. The team covers both inline and pipeline products for aligned therapeutic or franchise areas. Working at Novo Nordisk At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development to manufacturing, marketing, and sales – we’re all working to move the needle on patient care. Contact
Please contact [email protected] Linda McNamara for further information. Deadline
16 October 2023. We will interview candidates continually, as we receive the applications, so please apply as soon as you can. You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your resume / CV.
To ensure an efficient and fair recruitment process, please refrain from adding a photo to your CV.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk, we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company in the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds, and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve, and the communities we operate in. Together, we’re life-changing.
• Develop a sound understanding of relevant evidence needed for market access and their HEOR plans including health care resources utilization data, patient reported outcomes, quality of life, and real-world evidence
• Determine and deliver on Payer evidence generation strategies for pipeline products,
• Support payer-relevant clinical studies, including pragmatic studies, real-world evidence programs, patient-costed pathways, epidemiology, treatment patterns, patient preferences, cost, and burden of illness studies
• Key contributor to market access strategy building on best practice / payer-relevant models and evidence generation planning.
• Execute payer relevant evidence programs with high quality collection and statistical analyses expected by payers (PICO, MCID etc.)
• Work cross-functionally with subject matters experts in the identification, collection, synthesis and analysis of real-world datasets, and designing and executing real world pilot studies in partnership with affiliates and their payers and the impactful publication of the results.
Qualifications To be successful in this role, we imagine you should have: • Master’s degree in health economics or outcomes research, epidemiology, or statistics/biostatistics
• At least six years of experience in health economics and health outcomes research, ideally within the pharmaceutical industry or consultancy
• Extensive experience working within market access, digital health, and/or real-world evidence-generation
• Fluency in written and spoken English
On a personal level, it is expected that you have strong project and stakeholder management skills, as well as effective interpersonal communication skills. Be a team player. Additionally, you have a strategic and operational mindset, with a problem-solving approach that can identify solutions and influence decisions.
About the department
Rare Disease Access is a department within Rare Disease, driving change for patients in rare blood and rare endocrine disorders. Market Access is increasingly important for ensuring patients have access to best-in-class products and innovative solutions, as well as the commercial success of pharmaceutical products.
The Rare Disease Access Department is a highly diverse team, responsible for optimizing market access for the continued success of the Rare Disease franchise portfolios. In close collaboration with key internal stakeholders, we establish strategies and key support tactics around pricing, reimbursement, health economics & and outcomes research, and value communication, and subsequently support the implementation nationally, regionally, and locally. The team covers both inline and pipeline products for aligned therapeutic or franchise areas. Working at Novo Nordisk At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development to manufacturing, marketing, and sales – we’re all working to move the needle on patient care. Contact
Please contact [email protected] Linda McNamara for further information. Deadline
16 October 2023. We will interview candidates continually, as we receive the applications, so please apply as soon as you can. You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your resume / CV.
To ensure an efficient and fair recruitment process, please refrain from adding a photo to your CV.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk, we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company in the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds, and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve, and the communities we operate in. Together, we’re life-changing.
Information og data
Denne ledige stilling har jobtypen "Marketingmedarbejder", og befinder sig i kategorien "Kommunikation, marketing, salg".
Arbejdsstedet er beliggende i Søborg.
Jobbet er oprettet på vores service den 2.10.2023, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Marketingmedarbejder
- Søborg
Lignende jobs
-
Vil du være helten i børnenes hverdagseventyr? Vi ...
Få mere info- Marketingmedarbejder
- Taastrup
-
Marketing Data Analyst
Opportunity Join Our Team as a Digital Marketing Data Analyst!Maersk is a global leader in integrated logistics and have been industry pioneers for over a century. Through innovation and tran..Få mere info- Marketingmedarbejder
- København K
-
Marketing Graduate - Consumer Products Division - ...
Calling all innovators, disruptors, and dreamers! Join L’Oréal, the world's #1 beauty company present in over 150 markets. For over 100-years, we’ve been transforming, fueled by data, tech,.Få mere info- Marketingmedarbejder
- København
-
Marketingmedarbejder i Frederiksberg
Er du passioneret omkring design, kvalitet og produktudvikling? Har du en skarp sans for detaljer og erfaring med at lede projekter fra design til færdigt produkt? På vegne af 101 Copenhagen søger .Få mere info- Marketingmedarbejder
- Frederiksberg
Statistik over udbudte jobs som marketingmedarbejdere i Søborg
Herunder ser du udviklingen i udbudte marketingmedarbejder i Søborg over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal marketingmedarbejdere.
Se flere statistikker her:
Statistik over udbudte marketingmedarbejdere i Søborg over tid
| Dato | Alle jobs som marketingmedarbejdere |
|---|---|
| 30. oktober 2024 | 2 |
| 29. oktober 2024 | 2 |
| 28. oktober 2024 | 3 |
| 27. oktober 2024 | 4 |
| 26. oktober 2024 | 3 |
| 25. oktober 2024 | 3 |
| 24. oktober 2024 | 4 |
| 23. oktober 2024 | 3 |
| 22. oktober 2024 | 4 |
| 21. oktober 2024 | 4 |
| 20. oktober 2024 | 4 |
| 19. oktober 2024 | 4 |
| 18. oktober 2024 | 5 |
| 17. oktober 2024 | 4 |
| 16. oktober 2024 | 4 |
| 15. oktober 2024 | 4 |
| 14. oktober 2024 | 3 |
| 13. oktober 2024 | 3 |
| 12. oktober 2024 | 3 |
| 11. oktober 2024 | 3 |
| 10. oktober 2024 | 2 |
| 9. oktober 2024 | 3 |
| 8. oktober 2024 | 2 |
| 7. oktober 2024 | 2 |
| 6. oktober 2024 | 2 |
| 5. oktober 2024 | 2 |
| 4. oktober 2024 | 2 |
| 3. oktober 2024 | 2 |
| 2. oktober 2024 | 2 |
| 1. oktober 2024 | 1 |
| 30. september 2024 | 1 |